PASG

PASSAGE BIO INC

PASG·702712209·US·Common Stock·Healthcare - Biotechnology-Activist

PASG (PASSAGE BIO INC) is held by 17 institutional investors as of Q1 2026. Largest holders: RENAISSANCE TECHNOLOGIES LLC ($1M), VANGUARD CAPITAL MANAGEMENT LLC ($894,617), Erste Asset Management GmbH ($526,919). Net institutional sentiment: Mixed.

17
Holders
Avg rating(4 Elite)
$3.5M
Total Value
56% (22)
Fund Consensus
10 buying - 8 selling
PASGSmart Money Verdict
View all
Held by 17 funds
4 elite
Who's Trading
ActivistLYLynx1 Capital Management LP21.0%Jul 2, 2026
ActivistBABaselake Partners, LP7.3%Jun 25, 2026
InsiderCWChou WilliamSell $75KJan 8, 2026
InsiderBKBorthwick KathleenSell $38KJan 8, 2026
ActivistLYLYNX1 CAPITAL MANAGEMENT LP19.6%Nov 14, 2025
InsiderLLLynx1 Capital Management LPBuy $83KSep 15, 2025
InsiderLLLynx1 Capital Management LPBuy $138KSep 12, 2025
InsiderLLLynx1 Capital Management LPBuy $2KSep 11, 2025
InsiderLLLynx1 Capital Management LPBuy $379KJul 24, 2025
ActivistOAORBIMED ADVISORS LLC4.3%Jul 24, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
133,612(+22.5%)$1M0.0%-90.31%
30
New
113,964$894,6170.0%-42.88%
38
Unchanged
85,262$526,9190.0%-90.32%
0
Increased
41,380(+31.8%)$324,8780.0%-96.92%
20
Decreased
28,595(-1.1%)$224,4700.0%-65.64%
0
Increased
27,501(+1807.1%)$215,8830.0%-43.86%
25
New
17,049$133,8350.0%-42.88%
34
New
12,627$99,1220.0%-42.88%
30
Decreased
2,650(-38.0%)$20,8030.0%-58.11%
0
Increased
800(+60.0%)$6,2800.0%-52.83%
15
New
638$5,0080.0%-42.88%
23
Unchanged
212$1,6640.0%-92.51%
0
New
115$9030.0%-42.88%
17
Decreased
15(-25.0%)$1170.0%-64.80%
0
Unchanged
12$940.0%-62.36%
0
Unchanged
15$930.0%-55.37%
0
Exited
0(-100.0%)$148,4200.0%-25.23%
0
Exited
0(-100.0%)$127,4280.0%-1.72%
0
New
2$00.0%-42.88%
17
Exited
0(-100.0%)$167,7610.0%-25.23%
0

Showing 1-20 of 22

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used